Clin2
NCT07778836Possibly a fitRecruiting

Study of daily injections for Friedreich's ataxia

Friedreich AtaxiaFriedreich's Ataxia

Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests an investigational drug given as a daily injection to see if it can improve walking and balance in people with Friedreich's ataxia.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
150 people
Ages
12 years to 40 years
Study type
Interventional

Who can take part

  • You must have a genetic test showing two abnormal copies of the FXN gene.
  • You must be able to walk 25 feet in under 3 minutes (with or without a walking aid).
  • You must have moderate but not severe balance and coordination problems.
  • You (or a caregiver) must be able to give daily injections under the skin.
  • You must not be pregnant, breastfeeding, or planning pregnancy during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02497534Recruiting
Biomarker testing study for Friedreich’s ataxia

This study looks at “biomarkers” (measurable signs in the body, like test results from blood or other checks) in people with Friedreich’s ataxia. It may help researchers understand the disease better and track changes over time.

Gainesville, Florida
NCT07721025Recruiting· Phase 2
Gene therapy trial for Friedreich ataxia heart disease

This trial tests a one-time gene therapy called LX2006 for heart problems caused by Friedreich ataxia. The goal is to see if it can improve heart function and structure.

Tampa, Florida
NCT07870590Not yet recruiting· Phase 2
Study of GV101 for Friedreich's ataxia

This study tests a new medicine called GV101 to see if it can help people with Friedreich's ataxia, a condition that affects movement and balance. The trial will check if GV101 is safe and if it improves symptoms.

Eatontown, New Jersey
NCT06874010Recruiting· Phase 1/Phase 2
Study of DT-216P2 in adults with Friedreich's ataxia

This trial tests an investigational drug called DT-216P2 in people with Friedreich's ataxia. It aims to find the right dose and see how safe and tolerable it is.

Sydney, New South Wales
NCT06447025Recruiting· Phase 2
Study of CTI-1601 for people with Friedreich's ataxia

This trial tests an injectable medicine called CTI-1601 for Friedreich's ataxia (FRDA). It is an open-label study, meaning everyone knows they are getting the drug. The study is for people who have taken CTI-1601 before (without serious side effects) or are new to the drug.

Los Angeles, California
NCT06692296Recruiting
Balance training with a stabilometric platform for Friedreich's ataxia

This trial tests if a special platform that measures balance can help people with Friedreich's ataxia stand more steadily. If you have Friedreich's ataxia, can walk at least 10 metres and stand without support, you may be eligible.

Pieve di Soligo, Veneto

Hear when a new Friedreich Ataxia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.